valoctocogene roxaparvovec (Pending FDA Approval)

Brand and Other Names:Roctavian

Classes: Clotting Factors, Gene Therapy

Share
Email
Print
Feedback

Sections

Sections valoctocogene roxaparvovec
Dosing & Uses
Pharmacology
Images
Patient Handout

Dosing & Uses

Hemophilia A

Gene therapy pending FDA approval for hemophilia A

Mechanism of Action

Functional copy of the gene responsible for producing Factor VIII

Images

No images available for this drug.

Patient Handout

A Patient Handout is not currently available for this monograph.

Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.

[CLOSE WINDOW]

Sections valoctocogene roxaparvovec
Dosing & Uses
Pharmacology
Images
Patient Handout

valoctocogene roxaparvovec (Pending FDA Approval)

Dosing & Uses

Hemophilia A

Pharmacology

Mechanism of Action

Images

Patient Handout

What would you like to print?

Dosing Calculator